FMS · Fresenius Medical Care AG · Financials
Market Cap
$11.90B
Shares
532.22M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Diluted EPS
$4.06
+20.1%
FY2016
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EUR | — | 618.14M | 660.43M | 706.4M | 800.88M | 770.72M | — | — | — | — | — | — | — | — | — | — |
| EUR | — | 2.41B | 2.48B | 2.49B | 2.37B | 2B | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | $3.04B | $2.9B | $2.64B | $2.38B | $2.22B | $2B | $1.82B | $1.99B | $1.88B | $1.71B | |
| — | — | — | — | — | — | $118.43M | $110.36M | $98.48M | $93.1M | $87.44M | $77.85M | — | — | — | — | |
| — | — | — | — | — | — | $46.64M | $116.58M | $84.24M | $38.94M | $44.47M | $59.83M | $25.41M | $21.4M | $24.81M | $28.59M | |
| $0 | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | — | — | |
| — | — | — | — | — | — | -$64.91M | -$31.45M | -$24.84M | -$26.11M | -$17.44M | -$30.96M | -$8.95M | $4.53M | — | — | |
| — | — | — | — | — | — | $305.58M | $283.7M | $214.54M | $145.73M | $140.17M | $106.11M | $86.88M | $74.08M | $42.38M | $38.18M | |
| — | — | — | — | — | — | $1.26B | $780.89M | $508.11M | $1.05B | $1.18B | $779.43M | $834.2M | $992.7M | $565.45M | $823.42M | |
| USD/shares | — | — | — | — | — | — | $4.07 | $3.38 | $3.46 | $3.65 | $3.89 | $3.54 | $3.25 | $2.99 | $2.75 | $2.43 |
| USD/shares | — | — | — | — | — | — | $4.06 | $3.38 | $3.45 | $3.65 | $3.87 | $3.51 | $3.24 | $2.99 | $2.74 | $2.42 |
| shares | — | — | — | — | — | — | 305.75M | 304.44M | 302.34M | 301.88M | 301.14M | 299.01M | 296.81M | 294.42M | 293.23M | — |
| shares | — | — | — | — | — | — | 306.26M | 304.92M | 302.87M | 302.55M | 302.9M | 300.81M | 298.12M | 294.42M | 294.01M | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2016–FY2025: $1.65B in buybacks.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.
Key facts
CIK
1333141
CUSIP
358029106
13F (30d)
10 filings
9 filers
Visit website
Investor relations